Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL569689 | 0.81 | LMNA (0.60) | ALDH1A1LMNATSHRTHRBUSP2 | |
| Propylene Glycol SCHEMBL10542747 | 0.80 | — | — | |
| Glycerin SCHEMBL27945356 | 0.79 | LMNA (0.56) | ALDH1A1LMNATSHRTHRBUSP2 | |
| Glycerin SCHEMBL1446709 | 0.78 | — | — | |
| Glycerin SCHEMBL8102676 | 0.78 | LMNA (0.64) | ALDH1A1LMNATSHRTHRBUSP2 | |
| Glycerin SCHEMBL27587045 | 0.77 | LMNA (0.53) | ALDH1A1LMNATSHRTHRBUSP2 | |
| Glycerin SCHEMBL11207948 | 0.77 | LMNA (0.53) | ALDH1A1LMNATSHRTHRBUSP2 | |
| Glycerin SCHEMBL10475823 | 0.75 | LMNA (0.60) | ALDH1A1LMNATSHRTHRBUSP2 | |
| Glycerin SCHEMBL343633 | 0.75 | — | — | |
| Glycerin SCHEMBL13279055 | 0.75 | LMNA (0.60) | ALDH1A1LMNATSHRTHRBUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2512446-B1 | COMPOSITION OF DEXIBUPROFEN TRANSDERMAL HYDROGEL | SHASUN PHARMACEUTICALS LTD (IN) | 2015-04-08 | — | — | EP | claimed |
| CN-118121644-A | Application of sweet wormwood oil in inhibiting malassezia | 中国中医科学院中药研究所 | 2024-06-04 | — | — | CN | disclosed |
| CN-111163753-B | Inorganic sun-screening agent with high ultraviolet radiation protection | 维佐尔有限责任公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-4142680-B1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | UNILEVER IP HOLDINGS B V (NL) | 2023-10-18 | — | — | EP | disclosed |
| US-11707422-B2 | Inorganic sunscreen agents with higher UV radiation protection | VIZOR, LLC (US) | 2023-07-25 | — | — | US | disclosed |
| US-11679068-B2 | Hydroxy cinnamate and silanol adduct coated inorganic sunscreen agents | VIZOR, LLC (US) | 2023-06-20 | — | — | US | disclosed |
| US-20230165772-A1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230077649-A1 | Malodor Suppression in Brassica Amidoalkyl Containing Cosmetic Compositions | ARGUS LISA (US) | 2023-03-16 | — | — | US | disclosed |
| EP-4142680-A1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | Unilever IP Holdings B.V. (NL) | 2023-03-08 | — | — | EP | disclosed |
| CN-111182884-B | Inorganic sunscreen coated with adducts of hydroxycinnamic esters and silanols | 维佐尔有限责任公司 | 2023-01-31 | — | — | CN | disclosed |
| US-6410062-B1 | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) | JOHNSON & JOHNSON CONSUMER FRANCE SAS I3540 (FR) | 2002-06-25 | — | — | US | disclosed |
| US-20010055597-A1 | NOVEL TOPICAL COMPOSITIONS | JOHNSON & JOHNSON CONSUMER INC. | 2001-12-27 | — | — | US | disclosed |
| US-6193956-B1 | FOR USE IN CONTAINING SKIN CARE FORMULATIONS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2001-02-27 | — | — | US | disclosed |
| EP-1055720-A2 | Compositions for stabilizing oxygen-labile species | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2000-11-29 | — | — | EP | disclosed |
| US-6080393-A | COMPRISING RETINOL, RETINAL, RETINYL ACETATE, AND/OR RETINYL PALMITATE IN OIL PHASE WITH GIVEN TOTAL UNSATURATION DENSITY, AND STABILIZER SYSTEM OF ANTIOXIDANTS IN OIL PHASE OR OIL AND WATER PHASES, OR WATER PHASE CHELATING AGENTS; STORAGE STABLE | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 2000-06-27 | — | — | US | disclosed |
| US-5976555-A | EMULSIFIER SYSTEM | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0885000-A2 | TOPICAL COMPOSITIONS COMPRISING AN OIL-IN-WATER EMULSION AND A RETINOID | Johnson & Johnson Consumer Companies, Inc. (US) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997031620-A2 | TOPICAL COMPOSITIONS COMPRISING AN OIL-IN-WATER EMULSION AND A RETINOID | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 1997-09-04 | — | — | WO | disclosed |
| WO-1996007396-A9 | RETINOID COMPOSITIONS | — | 1996-09-06 | — | — | WO | disclosed |
| WO-1996007396-A2 | RETINOID COMPOSITIONS | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 1996-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165772-A1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | NAA40, CRAT, NQO1 | ALDH1A1 388/4885LMNA 3296/4885TSHR 4191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.